MedMen West Hollywood
In late 2015, MedMen took over management of an existing medical marijuana dispensary in West Hollywood, California, bringing a new level of immersive retail experience for cannabis consumers that is defining the industry.
MedMen Sun Valley
MedMen took over management of an indoor cultivation facility in Los Angeles in early 2016, one of a limited number of facilities permitted by the city. Using the latest in LED lighting technology and hydroponics, the facility can produce up to 50 percent more yield at four times lower cost than “legacy” operators.
In February 2017, MedMen took over management of an existing medical marijuana dispensary in Venice Beach, California, within walking distance of one of Southern California's most iconic tourist attractions. MedMen is also an investor in the project.
The 45,000-square-foot cannabis cultivation and production facility just outside Reno, Nevada is slated to open in the summer of 2017. MedMen is an investor in the $15 million project and will be manage the facility once it is operational. It includes a state-of-the-art Dutch style greenhouse that is projected to produce 10,000 pounds of cannabis annually.
The first MedMen managed medical marijuana dispensary in Orange County, California. The 8,000-square-foot retail facility will be one of only 20 licensed medical marijuana dispensaries in Santa Ana, one of the few municipalities in Orange County to allow marijuana dispensaries. MedMen is also an investor.
MedMen New York
In February 2017, MedMen completed the acquisition of Bloomfield Industries, at the time one of only five registered marijuana organizations licensed by the state of New York. MedMen is overseeing the upgrade of operations, including construction of a new high-tech cultivation and manufacturing facility in Utica, and a new dispensary in Manhattan. The facilities will operate under the MedMen brand.
MedReleaf is one of the leading cultivators, manufacturers and distributors of medical marijuana in Canada. MedReleaf and MedMen have long been research partners, and late in 2016 MedMen became an investor in the Canadian company giving the Los Angeles company a stake in one of the most advanced cannabis markets in the world.